Modulators of cystic fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2009308284 (hide)

Owner Vertex Pharmaceuticals, Incorporated

Inventors Binch, Hayley; Fanning, Lev T. D.; Hurley, Dennis; Sheth, Urvi; Silina, Alina; Yang, Xiaoqing; Botfield, Martyn; Grootenhuis, Peter D.J.; Van Goor, Fredrick; Numa, Mehdi Michel Djamel

Agent Cullens

Pub. Number AU-A-2009308284

PCT Pub. Number WO2010/048526

Priority 61/107,830 23.10.08 US

Filing date 23 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 453/04 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048526 Priority application(s): WO2010/048526

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308286-Data storage devices

2009308283-Systems, apparatuses and methods for cultivating microorganisms and mitigation of gases